The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.
What Is The Forecasted Market Size Trajectory Of The Rare Disease Registries Market From 2026 To 2030?
The rare disease registries market has shown rapid expansion in recent years. It is anticipated to grow from $1.62 billion in 2025 to $1.82 billion in 2026, achieving a compound annual growth rate (CAGR) of 12.6%. This historical development can be attributed to factors such as heightened awareness of rare diseases, increased clinical research endeavors, the proliferation of hospital and population-based registries, regulatory encouragement for patient data collection, and the restricted availability of structured patient data.
The rare disease registries market size is projected to experience swift expansion over the coming years, anticipated to reach $2.96 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 12.9%. This anticipated expansion throughout the forecast period stems from factors such as the implementation of AI-driven registry solutions, the integration of genomic and omics data, the broadening of personalized medicine initiatives, increased investment in cloud-based and interoperable platforms, and enhanced patient engagement and data sharing. Key developments expected during this period involve the real-time gathering of patient information, seamless integration with electronic health records (EHR), sophisticated data analytics tailored for rare diseases, optimized strategies for patient recruitment and retention, and the widespread use of interoperable registry platforms.
Access Your Free Sample Report For In-Depth Market Analysis:
Which Factors Are Influencing The Growth Of The Rare Disease Registries Market?
The expansion of the rare disease registries market is anticipated to be propelled by increasing government initiatives and funding assistance throughout the forecast period. These initiatives and financial backing include public-sector programs and monetary investments focused on enhancing healthcare infrastructure, fostering innovation, and elevating service provision. The rise in public funding signifies endeavors to bolster data-informed policymaking, streamline resource distribution, and better the results for marginalized patient groups, specifically those with rare diseases. Rare disease registries are instrumental in achieving these goals by collecting extensive patient data, which then guides policy formulation, aids in directing funds effectively, and allows for the creation and assessment of impactful healthcare and research programs. As an illustration, in February 2025, the UK government’s central executive body pledged around £26 billion ($35 billion) over two years to bolster the health and care system, thereby strengthening investments in data infrastructure and population health programs. Consequently, the increasing government initiatives and funding support are fueling the growth of the rare disease registries market.
Which Segment Types Are Examined In The Rare Disease Registries Market Segment Study?
The rare disease registries market covered in this report is segmented –
1) By Type: Product Registries, Health Services Registries, Disease Registries
2) By Database Type: Population-based, Hospital-based
3) By Software: Standalone, Integrated
4) By Function: Data Collection, Data Analysis, Patient Recruitment, Other Functions
5) By End-User: Pharmaceutical Companies, Research Organizations, Hospitals, Government Agencies, Other End-Users
Subsegments:
1) By Product Registries: Drug Product Registries, Biologic Product Registries, Medical Device Registries, Gene Therapy Product Registries
2) By Health Services Registries: Hospital Based Registries, Clinic Based Registries, National Health Program Registries, Insurance Claims Registries
3) By Disease Registries: Genetic Disorder Registries, Metabolic Disorder Registries, Neurological Disorder Registries, Oncology Rare Disease Registries
What Trends Are Transforming The Rare Disease Registries Market?
Leading companies in the **rare disease registries market** are concentrating on creating sophisticated products, notably AI-enabled patient registry infrastructure, designed to improve real-time data capture, patient oversight, and research understanding across rare diseases. This AI-enabled patient registry infrastructure represents systems that utilize artificial intelligence to efficiently process, analyze, and interpret extensive patient and clinical information, thereby facilitating predictive analytics, natural history modeling, and the generation of real-world evidence. For instance, in **May 2024**, the **National Organization for Rare Disorders (NORD)**, a US-based non-profit advocacy organization dedicated to individuals with rare diseases and the organizations that serve them, introduced the inaugural Canadian rare disease patient registries on its **IAMRARE** platform for **phenylketonuria (PKU)** and **mucopolysaccharidoses (MPS)**. This initiative enables real-time cooperative data collection, accommodates various languages and regional consent requirements, and offers crucial insights for clinical trial eligibility, monitoring disease progression, and evaluating treatment effectiveness.
Which Players Are Part Of The Competitive Landscape Of The Rare Disease Registries Market?
Major companies operating in the rare disease registries market are disease registries market are Deloitte Touche Tohmatsu Limited, International Business Machines Corporation, Oracle Corporation, BC Platforms Ltd., IQVIA Holdings Inc., ICON plc, Veeva Systems Inc., Alira Health Inc., Phastar Ltd., HealthVerity Inc., OM1 Inc., Synapse Laboratory, Castor EDC, RedCap Cloud, Within3 Inc., Sage Bionetworks, National Organization for Rare Disorders Inc., RTI Health Solutions, ArborMetrix Inc., Evado Clinical Systems Ltd., ClinCapture LLC, Global Vision Technologies Inc., Genetic Alliance UK, Pulse Infoframe.
Get The Full Rare Disease Registries Market Report:
https://www.thebusinessresearchcompany.com/report/rare-disease-registries-market-report
Which Region Leads The Rare Disease Registries Market In Terms Of Market Share?
North America was the largest region in the rare disease registries market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the rare disease registries market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Customized Rare Disease Registries Market Report For Competitive Insights:
Browse Through More Reports Similar to the Global Rare Disease Registries Market 2026, By The Business Research Company
pruritus therapeutic market report 2026
https://www.thebusinessresearchcompany.com/report/pruritus-therapeutic-global-market-report
genomic urine testing market report 2026
https://www.thebusinessresearchcompany.com/report/genomic-urine-testing-global-market-report
ocular genetic diagnostic market report 2026
https://www.thebusinessresearchcompany.com/report/ocular-genetic-diagnostic-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model